ID: ALA358662

Max Phase: Preclinical

Molecular Formula: C18H21NO

Molecular Weight: 267.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc2c1CCCC2NCc1ccccc1

Standard InChI:  InChI=1S/C18H21NO/c1-20-18-12-6-9-15-16(18)10-5-11-17(15)19-13-14-7-3-2-4-8-14/h2-4,6-9,12,17,19H,5,10-11,13H2,1H3

Standard InChI Key:  PMBJEYQADJMZJF-UHFFFAOYSA-N

Associated Targets(non-human)

Monoamine oxidase 94 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 267.37Molecular Weight (Monoisotopic): 267.1623AlogP: 3.86#Rotatable Bonds: 4
Polar Surface Area: 21.26Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.63CX LogP: 4.09CX LogD: 2.83
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.91Np Likeness Score: -0.43

References

1. McFarland JW, Gans DJ..  (1986)  On the significance of clusters in the graphical display of structure-activity data.,  29  (4): [PMID:3959029] [10.1021/jm00154a014]

Source